According to RSBNetwork, in a recent Agenda47 policy video, former President Trump made a bold promise to address the issue of drug shortages in the United States and bring the production of essential medicines back to the country. Trump expressed concern over the catastrophic increase in drug shortages under the Biden administration, citing a 30 percent rise in new drug shortages with a total of 295 active shortages by the end of 2022.
Trump’s plan involves dismantling the current medical landscape and ensuring the country’s independence from China as a means of pressuring pharmaceutical companies to relocate their production back to the United States. He emphasized his commitment to ending the nation’s reliance on China and claimed that Biden’s administration has shamefully failed to follow through on his previous executive order aimed at achieving this goal.
The former president highlighted the severity of the medicine shortage, noting that at least 14 cancer drugs were in short supply in the United States, which he claimed increased the risk of cancer-related deaths by at least 10 percent. He framed the issue as both a national security and public health crisis, underscoring the urgent need to address it.
Trump pledged to utilize tariffs and import restrictions as part of his plan to bring essential medicine production back to American soil. By doing so, he believes it will not only address the critical issue of drug shortages but also create numerous job opportunities for Americans. He positioned this effort as a top priority for his potential future presidency, expressing that American lives are at stake, and he is determined to take decisive action.
#Agenda47: Returning Production of Essential Medicines Back to America and Ending Biden’s Pharmaceutical Shortages pic.twitter.com/DkNJu5JWHX
— Team Trump (Text TRUMP to 88022) (@TeamTrump) July 24, 2023
